Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. 2016

Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

BACKGROUND Five or more colorectal liver metastases (CRLM) are considered marginally resectable and cannot be treated solely by hepatic resection (Hr). This study investigated the long-term effectiveness of surgical treatment using microwave coagulo-necrotic therapy (MCN) and/or Hr for marginally resectable or unresectable multiple CRLM. METHODS This study retrospectively analyzed 82 consecutive CRLM patients with ≥5 CRLM who underwent MCN, Hr, or both, at our institution from 1994 to 2012. Presuming all CRLM were resected curatively, virtual remnant liver volume was calculated using preoperative computed tomography or magnetic resonance imaging. Virtual remnant liver volume <30% was defined as unresectable. Patients were divided into marginally resectable (Group Y; n=29) and unresectable (Group N; n=53). Overall and recurrence-free survival were assessed. RESULTS Mean maximum tumor diameter and tumor number were 3.1 and 6.0 cm in Group Y and 3.3 and 11.3 cm in Group N. Surgical methods included MCN (n=16), MCN+Hr (n=9), and Hr (n=4) in Group Y, and MCN (n=28) and MCN+Hr (n=25) in Group N. One- and 2-year recurrence-free survival rates were 38.0% and 22.8% in Group Y, and 18.9% and 3.8% in Group N (P=0.01). However, 1-, 3-, and 5-year overall survival rates of Group N (86.8%, 44.6%, and 33.7%, respectively) were similar to those of Group Y (82.8%, 51.4%, and 33.3%, respectively; P= not significant each). CONCLUSIONS MCN may improve survival for patients with unresectable multiple CRLM, similar to that in patients with marginally resectable multiple CRLM.

UI MeSH Term Description Entries

Related Publications

Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
April 1993, Nihon rinsho. Japanese journal of clinical medicine,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
May 2006, Nihon Geka Gakkai zasshi,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
January 2013, Nihon Geka Gakkai zasshi,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
May 1996, Nihon rinsho. Japanese journal of clinical medicine,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
January 2012, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
June 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
January 2011, Khirurgiia,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
October 2001, Gan to kagaku ryoho. Cancer & chemotherapy,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
October 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
Yoshiyuki Wada, and Yuko Takami, and Masaki Tateishi, and Tomoki Ryu, and Kazuhiro Mikagi, and Hideki Saitsu
October 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!